A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)
Clinical trial NCT06767735 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06767735
- Sponsor
- Gan & Lee Pharmaceuticals.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-17
- Primary completion
- 2026-08-01
- Enrollment
- 580
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.